Fig. 3From: Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysisForest plots showing the results of meta-analysis comparing SVR12/24 in patients with cirrhosis versus patients without cirrhosisBack to article page